JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares -9.5% ·
flujo de acciones -2.2% ·
nuevas posiciones netas -10.5%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.13B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 56.11M | +1.8% | $9.06B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 56.11M | +1.8% | $9.06B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (pasivo) | 29.04M | -0.2% | $4.71B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 25.16M | +1.0% | $4.08B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 25.16M | +1.0% | $4.08B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 7.56M | +7.9% | $1.23B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 1.62M | +89.9% | $262.40M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 1.47M | -54.1% | $238.25M | 1.3% | ▼ Trim | 2 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 1.15M | +39.2% | $186.83M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 25 | Tweedy, Browne ✦ | 1.13M | -0.4% | $182.51M | 8.7% | ▼ Trim | 2 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 657.80K | -54.8% | $106.60M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 657.80K | -54.8% | $106.60M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | Markel Group ✦ | 610.80K | 0.0% | $98.99M | 0.9% | Held | 2 | SEC ↗ |
| 29 | Markel Group ✦ | 610.80K | 0.0% | $98.99M | 0.9% | Held | 2 | SEC ↗ |
| 30 | Gotham Asset Management ✦ | 217.64K | -0.2% | $35.27M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 204.36K | -82.4% | $33.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 204.36K | -82.4% | $33.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | GAMCO Investors ✦ | 96.58K | -1.8% | $15.65M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 34 | Millennium Management ✦ | 81.37K | -92.4% | $13.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Fairfax Financial ✦ | 73.40K | 0.0% | $11.89M | 1.1% | Held | 2 | SEC ↗ |
| 36 | Dodge & Cox ✦ | 21.10K | 0.0% | $3.42M | 0.0% | Held | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Renaissance Technologies | $223.58M | era 0.4% |
| Two Sigma Investments | $94.97M | era 0.2% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 136.10K acciones, $33,268 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 15.00K acc. · $3.95M
Officer, Director · 20.98K acc. · $5.50M
Officer, Director · 102.31K acc. · $26.70M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a…
Reuters